Moreover, MS patients had a significant number of IL-17 mRNA-positive MNC in the CSF compared with control patients suffering from other noninflammatory neurological disease, indicating an enrichment or accumulation of Th17 cells at sites of inflammation in MS. Here, IL17A is linked to myeloid sarcoma.